Fertilization offsets the maternal age effect on mouse oocytes provided the oviduct is not itself aged

Technical Summary: Fertilization Offsets the Maternal Age Effect on Mouse Oocytes Provided the Oviduct is Not Itself Aged

Problem Statement
Advanced maternal age is widely recognized to compromise oocyte quantity and quality, leading to reduced fertility and adverse developmental outcomes. The prevailing narrative assumes that deficits in aged oocytes (such as aneuploidy, mitochondrial dysfunction, and altered gene expression) are propagated directly to the resulting embryos. However, most existing studies rely on in vivo conception, where the aged oocyte is inseparable from the aged reproductive tract (oviduct and uterus) and potentially aged paternal factors. This confounding makes it difficult to distinguish whether developmental failure is caused by intrinsic oocyte defects, the aged maternal environment, or a combination of both. While some historical data suggest that aged oocytes can support term development when transferred to young recipients, the molecular mechanisms underlying this potential "reversal" of aging in the embryo remain poorly understood, particularly at the proteomic level.

Methodology
The authors employed a rigorous experimental design using B6C3F1 mice to decouple the age of the oocyte from the age of the maternal environment and paternal contribution.

• Animal Models: Young (2 months) and aged (12–15 months) females were used. Aged females exhibited expected hallmarks: follicle depletion, reduced ovulation rates (~70% drop), and increased aneuploidy.
• Experimental Groups:
  1. In Vivo: Aged and young females were mated with young males to assess natural conception and implantation rates.
  2. In Vitro Fertilization (IVF): Oocytes from both age groups were fertilized in vitro using a shared sperm preparation from young CD1 males. This controlled for paternal variability and removed the aged oviduct.
  3. Parthenogenesis: Oocytes were activated without sperm to isolate the contribution of the oocyte itself from the fertilization stimulus.
• Omics and Molecular Analysis:
  • Proteomics: Data-independent acquisition (DIA) mass spectrometry was performed on oocytes and blastocysts. Low-input pipelines were used for blastocysts.
  • Transcriptomics: RNA-seq was conducted on blastocysts to compare with proteomic data.
  • Protein Turnover: Stable Isotope Labeling by Amino acids in Cell culture (SILAC) using heavy Arg-10 and Lys-8 was applied to live embryos to distinguish newly synthesized proteins from inherited maternal proteins.
  • Synthesis Imaging: O-propargyl-puromycin (OPP) labeling was used to visualize de novo protein synthesis.
  • Functional Assays: Immunofluorescence for cell lineage markers (CDX2, SOX17, NANOG) and embryo transfer to young pseudo-pregnant recipients to assess development to term (E18.5).

Key Results

1. In Vivo vs. In Vitro Discrepancy: In in vivo mating, the fraction of ovulated oocytes forming implantation sites in aged females dropped ~3.7-fold compared to young females. However, when aged oocytes were fertilized in vitro and transferred to young oviducts, they developed to blastocysts and term at rates comparable to, or slightly higher than, young controls.
2. Proteomic Reversal:
   • Oocytes: Aged oocytes showed a proteomic signature characterized by a significant downregulation of proteins related to ribosomes, mRNA splicing, and protein synthesis.
   • Blastocysts (IVF): In contrast, blastocysts derived from aged oocytes via IVF did not inherit this downregulation. Instead, proteins associated with ribosomes and splicing were upregulated in aged-derived blastocysts compared to young-derived ones. This represents a "DOWN→UP" flux reversal.
   • Blastocysts (Parthenogenesis): This reversal was absent in parthenogenetic embryos. In the absence of sperm, the proteomic signature of the aged oocyte (downregulation of specific machinery) was largely retained or propagated differently, failing to show the compensatory upregulation seen in IVF.
3. Mechanism of Compensation:
   • SILAC Analysis: Fertilization triggered a dual mechanism in aged embryos: an increase in de novo protein synthesis (heavy channel) and an accelerated clearance of inherited maternal proteins (light channel). This resulted in a higher ratio of new-to-old protein in aged blastocysts compared to young ones.
   • Parthenogenesis: This dual mechanism (increased synthesis + increased clearance) was not observed in parthenotes; aged parthenotes retained more maternal protein and did not show the same synthesis boost.
   • Specificity: The "rejuvenation" effect was sperm-dependent. The aged oocyte appeared to be pre-provisioned with elevated levels of specific maternal factors (e.g., IP3 receptor ITPR1, calcium/calmodulin kinase CAMK2G, nucleoplasmin NPM2) involved in sperm handling and chromatin remodeling, which were largely inherited rather than newly synthesized.
4. Developmental Competence: Despite the initial proteomic deficits in aged oocytes, IVF-derived blastocysts from aged mothers showed no functional deficits in cell lineage allocation (trophectoderm, primitive endoderm, epiblast) and successfully developed to term when transferred to young recipients.

Significance and Claims
The paper claims that the "maternal age effect" on the oocyte proteome is labile rather than fixed. The study demonstrates that:

• The developmental deficits associated with maternal age are not solely intrinsic to the oocyte but are heavily influenced by the aged reproductive tract and the lack of a specific fertilization stimulus.
• Fertilization itself acts as a driver of proteomic remodeling. The entry of the spermatozoon triggers a compensatory program in the embryo that involves both the synthesis of new proteins and the active clearance of the aged maternal proteome.
• This compensatory mechanism is sperm-dependent; mere embryonic cleavage (as seen in parthenogenesis) is insufficient to offset the proteomic age signature.
• The study challenges the strict propagation hypothesis, suggesting that if the maternal environment is not aged and the stimulus is a spermatozoon, the molecular legacy of maternal aging can be largely offset, allowing embryos from aged oocytes to develop normally.

The authors conclude that while aneuploidy remains a fixed barrier, the broader molecular legacy of the aged oocyte is reversible through the specific biological events of fertilization, offering a nuanced view of reproductive aging that distinguishes between the oocyte's intrinsic state and its interaction with the fertilization environment.